[1]
Rajdan, N., Srivastava, B., Titiyal, G.S., Shujauddin and Kapri, S. 2025. Comparative study to evaluate efficacy and safety of topical alcaftadine 0.25% versus topical olopatadine 0.2% eye drops in patients with allergic conjunctivitis in a tertiary care teaching hospital, Haldwani. International Journal of Basic & Clinical Pharmacology. 14, 2 (Jan. 2025), 165–170. DOI:https://doi.org/10.18203/2319-2003.ijbcp20250002.